- Trials with a EudraCT protocol (58)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
58 result(s) found for: Sensory loss.
Displaying page 1 of 3.
EudraCT Number: 2011-000922-31 | Sponsor Protocol Number: Cognitivefunction2011001 | Start Date*: 2011-04-18 | |||||||||||
Sponsor Name:Karolinska Institutet | |||||||||||||
Full Title: Patients´ recovery day 0-3 after short-stay elective surgery – a pilot study comparing desflurane and propofol TCI as main anaesthetics. | |||||||||||||
Medical condition: Patients undergoing elective general anaesthesia for breat surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006037-41 | Sponsor Protocol Number: CISN2O | Start Date*: 2006-12-21 | |||||||||||
Sponsor Name:Klaus Olkkola | |||||||||||||
Full Title: Interaction of cisatracurium with nitrous oxide as quantified by closed-loop feedback control / Typpioksiduulin vaikutus sisatrakuurin annostarpeeseen käytettäessä sisatrakuurin tietokoneohjattua a... | |||||||||||||
Medical condition: Tutkimuksen kohderyhmänä ovat potilaat, joille tehdään yleisanestesiaa vaativa leikkaus, jonka kesto on vähintään 90 min. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002827-14 | Sponsor Protocol Number: TreatSPG11 | Start Date*: 2021-01-19 | |||||||||||
Sponsor Name:IRCCS Fondazione Stella Maris | |||||||||||||
Full Title: Phase 2 pharmacological experimental study to test the safety of miglustat in subjects with hereditary spastic paraplegia type 11 | |||||||||||||
Medical condition: Spastic paraparesis type 11 (SPG11), caused by mutations in spatacsin protein, is characterized by the association of peripheral neuropathy, parkinsonism, ataxia, cognitive impairment, hypotrophy o... | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004033-13 | Sponsor Protocol Number: EMA401-005 | Start Date*: 2012-02-06 | |||||||||||
Sponsor Name:Spinifex Pharmaceuticals Pty Ltd | |||||||||||||
Full Title: A Phase 2 open label biomarker study of angiotensin II type 2 receptor antagonist EMA401 for the treatment of pain in patients with chemotherapy-induced peripheral neuropathy. | |||||||||||||
Medical condition: Chemotherapy induced peripheral neuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000132-40 | Sponsor Protocol Number: AM-111-CL-08-01 | Start Date*: 2008-11-18 | |||||||||||
Sponsor Name:Auris Medical AG | |||||||||||||
Full Title: Efficacy of AM 111 in Patients with Acute Sensorineural Hearing Loss: A Multi-Centre, Double-Blind, Randomised, Placebo-Controlled, Dose-Escalation Phase II Study | |||||||||||||
Medical condition: Acute sensorineural hearing loss (ASNHL), which may be triggered by acoustic trauma, middle or inner ear surgery, i.e. known or evident insults to the inner ear. ASNHL may also result from a variet... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-001920-31 | Sponsor Protocol Number: DMID11-0069 | Start Date*: 2014-12-09 | ||||||||||||||||||||||||||
Sponsor Name:University College London | ||||||||||||||||||||||||||||
Full Title: A PHASE II RANDOMIZED AND CONTROLLED INVESTIGATION OF SIX WEEKS OF ORAL VALGANCICLOVIR THERAPY IN INFANTS AND CHILDREN WITH CONGENITAL CYTOMEGALOVIRUS INFECTION AND HEARING LOSS. | ||||||||||||||||||||||||||||
Medical condition: Children born with congenital CMV infection may develop sequelae on follow-up, particularly sensorineural hearing loss. A recent systematic review reports that 13.5% of babies with congenital CMV ... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-002643-41 | Sponsor Protocol Number: SM1-KHTY-16 | Start Date*: 2016-08-29 | |||||||||||
Sponsor Name:Department of Anesthesiology, Næstved Hospital | |||||||||||||
Full Title: Sensory distribution of lateral femoral cutaneous nerve block - a randomised, blinded, paired trial in heathy volunteers | |||||||||||||
Medical condition: Healthy volunteers (treatment intended for pain treatment in patients after hip surgery) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000846-20 | Sponsor Protocol Number: ANE-INTRA-2013 | Start Date*: 2013-06-24 | |||||||||||
Sponsor Name:Fundació Parc Taulí | |||||||||||||
Full Title: Comparison of the effects of bupivacain or levobupivacain on cerebral oxigenation during intradural anesthesia in elderly patients who undergo major orthopaedic surgery for hip replacement | |||||||||||||
Medical condition: Intradural anaesthesia | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001493-32 | Sponsor Protocol Number: RC 16/07 | Start Date*: 2008-06-09 | |||||||||||
Sponsor Name:ISTITUTO PER L'INFANZIA BURLO GAROFOLO | |||||||||||||
Full Title: Comparison between two different sedation strategies (propofol versus propofol plus ketamine) in deep sedation managed by non anesthesiologists. | |||||||||||||
Medical condition: Procedural deep sedation (gastrointestinal endoscopy, lumbar puncture, etc) | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004343-76 | Sponsor Protocol Number: NMBA_ELDERLY2019ROCU_DOSES | Start Date*: 2020-02-27 | |||||||||||
Sponsor Name:Rigshospitalet | |||||||||||||
Full Title: A single-blinded multicenter randomized interventional study of rocuronium 0.3 mg/kg, and 0.9 mg/kg comparing onset time, duration of action and effect on intubating conditions in elderly patients ... | |||||||||||||
Medical condition: The aim of this study is to determine the onset time, duration of action and effect on intubating conditions after rocuronium 0.3 mg/kg and 0.9 mg/kg in patients with age ≥ 80 years. | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001854-74 | Sponsor Protocol Number: RBHP-2021-ELJEZI | Start Date*: 2021-07-28 | ||||||||||||||||
Sponsor Name:CHU de Clermont-Ferrand | ||||||||||||||||||
Full Title: - | ||||||||||||||||||
Medical condition: - | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001742-41 | Sponsor Protocol Number: FLUDRO-2007 | Start Date*: 2009-06-04 | |||||||||||
Sponsor Name:Dr. Daniel López Aguado. Servicio de Otorrinolaringología. Hospital Universitario de Canarias | |||||||||||||
Full Title: ENSAYO CLÍNICO ALEATORIZADO FASE IV PARA EVALUAR LA EFICACIA COMPARATIVA DEL TRATAMIENTO CON VASODILATADORES, GLUCOCORTICOIDES Y MINERALOCORTICOIDES EN PACIENTES CON HIPOACUSIA NEUROSENSORIAL IDIO... | |||||||||||||
Medical condition: Hipoacusia neurosensorial idiopática | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000066-37 | Sponsor Protocol Number: NM-V-101 | Start Date*: 2013-01-16 | |||||||||||
Sponsor Name:Nordmark Arzneimittel GmbH & Co. KG | |||||||||||||
Full Title: Double-blind, randomized, placebo-controlled study on efficacy, safety and tolerability of ancrod in patients with sudden sensorineural hearing loss | |||||||||||||
Medical condition: sudden sensorineural hearing loss (SSHL) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004936-39 | Sponsor Protocol Number: SM2-KHT-2016 | Start Date*: 2017-02-01 | |||||||||||
Sponsor Name:Department of Anesthesiology, Næstved Hospital | |||||||||||||
Full Title: The influence of different doses of local anaesthetics on the sensory distribution of lateral femoral cutaneous nerve block - a randomised, blinded, paired trial in heathy volunteers | |||||||||||||
Medical condition: Healthy volunteers (treatment intended for pain treatment in patients after hip surgery) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000812-47 | Sponsor Protocol Number: SENS401-201 | Start Date*: 2018-09-24 | |||||||||||
Sponsor Name:SENSORION SA | |||||||||||||
Full Title: A two- part, randomized, double-blind, placebo-controlled, parallel-group, efficacy and safety study of SENS-401 in subjects with severe or profound sudden sensorineural hearing loss | |||||||||||||
Medical condition: Sudden sensorineural hearing loss (SSNHL) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) BG (Completed) CZ (Completed) GB (GB - no longer in EU/EEA) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000242-22 | Sponsor Protocol Number: STR001-202 | Start Date*: 2017-06-28 | |||||||||||
Sponsor Name:STREKIN AG | |||||||||||||
Full Title: A Phase III multicenter, double-blind, placebo-controlled, study evaluating the safety, and efficacy of STR001 treatment in adults with Sudden Sensorineural Hearing Loss | |||||||||||||
Medical condition: Sudden Sensorineural Hearing Loss (SSHL) including - idiopathic unilateral Sensorineural Hearing Loss - acute uni- or bilateral acoustic trauma-induced Sensorineural Hearing Loss | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-013892-23 | Sponsor Protocol Number: 1A-RSI-SU | Start Date*: 2009-08-19 | |||||||||||||||||||||
Sponsor Name:Rigshospitalet | |||||||||||||||||||||||
Full Title: ”Akut indledning” med Rocuronium-Sugammadex sammenlignet med Suxamethon | |||||||||||||||||||||||
Medical condition: Akut indledning ved universel anæstesi | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-003172-36 | Sponsor Protocol Number: 29.06.2011 | Start Date*: 2011-10-07 | |||||||||||||||||||||
Sponsor Name:Department of Anaesthesia, Tampere University Hospital | |||||||||||||||||||||||
Full Title: Arousal reaction during desflurane anaesthesia | |||||||||||||||||||||||
Medical condition: The patients who undergo abdominal surgeries (laparotomy or laparoscopy) under desflurane anaesthesia will be investigated. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FI (Prematurely Ended) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005026-35 | Sponsor Protocol Number: 35RC14_9853_DEXA-OP | Start Date*: Information not available in EudraCT | ||||||||||||||||
Sponsor Name:Centre Hospitalier Universitaire de Rennes | ||||||||||||||||||
Full Title: Study DEXA-OP. Can the dexaméthasone replace the kétoprofène in the strategy of per-operating multimodal analgesia in pediatric ambulatory surgery? A double-blind randomized comparative study. | ||||||||||||||||||
Medical condition: Per-operating analgesia, pediatric ambulatory surgery | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003233-14 | Sponsor Protocol Number: 18CH129 | Start Date*: Information not available in EudraCT | |||||||||||||||||||||
Sponsor Name:CHU de Saint Etienne | |||||||||||||||||||||||
Full Title: Evaluation of the neonatal autonomic stress during intubations under Propofol in a population of premature infants under 33 w’GA | |||||||||||||||||||||||
Medical condition: population of premature infants under 33 w’GA requiring intubation for the administration of exogenous surfactant | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FR (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
